-- Post hoc analysis of UPLIZNA Phase 2/3 trial shows all seven patients who had attacks while receiving rituximab were attack-free after switching to UPLIZNA -- UPLIZNA is the first and only ...

BTK inhibitors such as tolebrutinib or evobrutinib work about as well as Aubagio at preventing relapses in MS, a review of studies found.

"In terms of association with climate, our results suggest a relationship between enhancing lesions and tropical nights, a variable indicating extreme temperatures, which had not been previously ...

A brief, four-session stress management program helped ease symptoms of depression and anxiety and reduced stress in people ...

Mediterranean, plant-based, and anti-inflammatory diets are associated with reduced C-reactive protein levels in people with multiple sclerosis.

According to a 2019 study funded by the National Multiple Sclerosis Society, almost 1 million people in the US have received a diagnosis of the disorder. MS is a chronic neurological disorder where ...

—Evidence from a recent study found that improvement in depression symptoms was associated with a reduction in physical, cognitive, and social fatigue in patients with multiple sclerosis. As ...

Scientists have long suspected that industrial pollutants might help trigger multiple sclerosis, but the latest evidence ...

Some research suggests that people with multiple sclerosis are at a higher risk of atherosclerosis. An increased risk hasn’t been established, and we don’t know how MS might increase the risk. Having ...

Multiple sclerosis (MS) and anxiety often occur together. If you live with MS and anxiety, there may be ways you can reduce the impact of this challenging combination. MS is an autoimmune disease in ...

Managing multiple sclerosis (MS) is not a straight path. From getting diagnosed to treating symptoms, it’s a journey of ups and downs. Nearly one million people in the United States have MS and ...